The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy

BACKGROUND: Glucocorticoid therapy is the most common cause of iatrogenic osteoporosis. Less is known regarding the effect of glucocorticoids when used as replacement therapy on bone remodelling in patients with adrenal insufficiency. Enhanced intracellular conversion of inactive cortisone to active...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Endocr Disord
Autors principals: Dineen, Rosemary, Behan, Lucy-Ann, Kelleher, Grainne, Hannon, Mark J., Brady, Jennifer J., Rogers, Bairbre, Keevil, Brian G., Tormey, William, Smith, Diarmuid, Thompson, Christopher J., McKenna, Malachi J., Arlt, Wiebke, Stewart, Paul M., Agha, Amar, Sherlock, Mark
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7547490/
https://ncbi.nlm.nih.gov/pubmed/33036588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-020-00633-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars